Orexin agonism

搜索文档
Takeda(TAK) - 2026 Q1 - Earnings Call Transcript
2025-07-30 19:02
Takeda Pharmaceutical Company (TAK) Q1 2026 Earnings Call July 30, 2025 06:00 AM ET Company ParticipantsChristopher David O'Reilly - Global Head of Investor RelationsChristophe Weber - President, CEO & Representative DirectorMilano Furuta - Director - CFOAndrew Plump - President - Research & Development & DirectorHidemaru Yamaguchi - Managing DirectorJulie Kim - President of the U.S. Business Unit & U.S. Country HeadStephen B - Managing DirectorMichael Nedelcovych - Director - Equity ResearchConference Call ...